Drug-induced psoriasis: clinical perspectives
Deepak MW Balak, Enes Hajdarbegovic Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands Abstract: Exposure to certain drugs can elicit an induction or exacerbation of psoriasis. Although well-conducted systematic studies on drug-related psoriasis are mos...
Guardado en:
Autores principales: | Balak DMW, Hajdarbegovic E |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b3309adb24cc441e9dd0bb9f6c2f7ff9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diagnostic utility of Ki-67 and Cyclin D1 immunostaining in differentiation of psoriasis vs. other psoriasiform dermatitis
por: Engin Sezer, et al.
Publicado: (2015) -
Spotlight on itolizumab in the treatment of psoriasis – current perspectives from India
por: Budamakuntla L, et al.
Publicado: (2019) -
Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of a 54-week randomized double-blind placebo-controlled PLANETA clinical trial
por: Luis Puig, et al.
Publicado: (2021) -
Drug Intake and Actinic Keratosis: A Case-Control Study
por: Andrea Sechi, et al.
Publicado: (2021) -
Dermoscopic Aspects of Cutaneous Adverse Drug Reactions
por: Gabriela Rossi, et al.
Publicado: (2021)